SOD1 Oligomers in Amyotrophic Lateral Sclerosis

Overview

Journal Curr Opin Struct Biol

Date 2021 Jan 19

PMID 33465527

Citations 14

Authors

Esther S Choi

Nikolay V Dokholyan

Affiliations

Soon will be listed here.

Abstract

Identifying nonnative, trimeric forms of SOD1 trimers as the toxic species, rather than large aggregates revolutionizes our understanding of ALS pathophysiology. Large protein aggregates, what was previously thought as the central cause of neurodegeneration, play protective role and are not responsible for neuronal death. SOD1 trimers are implicated at the molecular, cellular, and organismal level. Understanding the formation of the nonnative trimer and its role in the cell, leading to cell death, holds the key to developing a new standard of therapeutics for ALS and for other neurodegenerative diseases. This review highlights recent advances of knowledge for the role of SOD1 oligomers in ALS.

Citing Articles

Unveiling the double-edged sword: SOD1 trimers possess tissue-selective toxicity and bind septin-7 in motor neuron-like cells.

Choi E, Hnath B, Sha C, Dokholyan N Structure. 2024; 32(10):1776-1792.e5.

PMID: 39208794 PMC: 11455619. DOI: 10.1016/j.str.2024.08.002.

Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS.

Tsekrekou M, Giannakou M, Papanikolopoulou K, Skretas G Front Mol Biosci. 2024; 11:1383453.

PMID: 38855322 PMC: 11157337. DOI: 10.3389/fmolb.2024.1383453.

Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications.

Huang M, Liu Y, Yao X, Qin D, Su H Transl Neurodegener. 2024; 13(1):28.

PMID: 38811997 PMC: 11138100. DOI: 10.1186/s40035-024-00416-x.

Structural insights into the modulation Of SOD1 aggregation By a fungal metabolite Phialomustin-B: Therapeutic potential in ALS.

Unni S, Kommu P, Aouti S, Nalli Y, Srinivas Bharath M, Ali A PLoS One. 2024; 19(3):e0298196.

PMID: 38446760 PMC: 10917278. DOI: 10.1371/journal.pone.0298196.

Implications of ALS-Associated Mutations on Biochemical and Biophysical Features of hSOD1 and Aggregation Formation.

Mohammadi S, Seyedalipour B, Hashemi S, Hosseinkhani S, Mohseni M Biochem Genet. 2024; 62(5):3658-3680.

PMID: 38196030 DOI: 10.1007/s10528-023-10619-y.

References

Zetterstrom P, Stewart H, Bergemalm D, Jonsson P, Graffmo K, Andersen P . Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc Natl Acad Sci U S A. 2007; 104(35):14157-62. PMC: 1955813. DOI: 10.1073/pnas.0700477104. View

Al-Chalabi A, Hardiman O . The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013; 9(11):617-28. DOI: 10.1038/nrneurol.2013.203. View

Lee D, Jeon G, Sung J . ALS-Linked Mutant SOD1 Associates with TIA-1 and Alters Stress Granule Dynamics. Neurochem Res. 2020; 45(12):2884-2893. DOI: 10.1007/s11064-020-03137-5. View

Atlasi R, Malik R, Corrales C, Tzeplaeff L, Whitelegge J, Cashman N . Investigation of Anti-SOD1 Antibodies Yields New Structural Insight into SOD1 Misfolding and Surprising Behavior of the Antibodies Themselves. ACS Chem Biol. 2018; 13(9):2794-2807. PMC: 6475120. DOI: 10.1021/acschembio.8b00729. View

Medinas D, Gozzo F, Santos L, Iglesias A, Augusto O . A ditryptophan cross-link is responsible for the covalent dimerization of human superoxide dismutase 1 during its bicarbonate-dependent peroxidase activity. Free Radic Biol Med. 2010; 49(6):1046-53. DOI: 10.1016/j.freeradbiomed.2010.06.018. View

Nicholson K, Murphy A, McDonnell E, Shapiro J, Simpson E, Glass J . Improving symptom management for people with amyotrophic lateral sclerosis. Muscle Nerve. 2017; 57(1):20-24. DOI: 10.1002/mus.25712. View

Rothstein J . Edaravone: A new drug approved for ALS. Cell. 2017; 171(4):725. DOI: 10.1016/j.cell.2017.10.011. View

Dong Q, Zhu J, Liu S, Yu X, Liu R . An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS. Int Immunopharmacol. 2018; 65:413-421. DOI: 10.1016/j.intimp.2018.10.032. View

Kiernan M, Vucic S, Cheah B, Turner M, Eisen A, Hardiman O . Amyotrophic lateral sclerosis. Lancet. 2011; 377(9769):942-55. DOI: 10.1016/S0140-6736(10)61156-7. View

10.

Bille A, Steen Jensen K, Mohanty S, Akke M, Irback A . Stability and Local Unfolding of SOD1 in the Presence of Protein Crowders. J Phys Chem B. 2019; 123(9):1920-1930. DOI: 10.1021/acs.jpcb.8b10774. View

11.

Gill C, Phelan J, Hatzipetros T, Kidd J, Tassinari V, Levine B . SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS. Sci Rep. 2019; 9(1):6724. PMC: 6491559. DOI: 10.1038/s41598-019-43164-z. View

12.

Ghasemi M, Brown Jr R . Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harb Perspect Med. 2017; 8(5). PMC: 5932579. DOI: 10.1101/cshperspect.a024125. View

13.

Srinivasan E, Rajasekaran R . Cysteine to Serine Conversion at 111th Position Renders the Disaggregation and Retains the Stabilization of Detrimental SOD1 A4V Mutant Against Amyotrophic Lateral Sclerosis in Human-A Discrete Molecular Dynamics Study. Cell Biochem Biophys. 2017; 76(1-2):231-241. DOI: 10.1007/s12013-017-0830-5. View

14.

Petrov D, Mansfield C, Moussy A, Hermine O . ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?. Front Aging Neurosci. 2017; 9:68. PMC: 5360725. DOI: 10.3389/fnagi.2017.00068. View

15.

Brenner D, Weishaupt J . Update on amyotrophic lateral sclerosis genetics. Curr Opin Neurol. 2019; 32(5):735-739. DOI: 10.1097/WCO.0000000000000737. View

16.

McAlary L, Plotkin S, Yerbury J, Cashman N . Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis. Front Mol Neurosci. 2019; 12:262. PMC: 6838634. DOI: 10.3389/fnmol.2019.00262. View

17.

Pokrishevsky E, Hong R, Mackenzie I, Cashman N . Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells. PLoS One. 2017; 12(9):e0184384. PMC: 5587256. DOI: 10.1371/journal.pone.0184384. View

18.

Kaur S, McKeown S, Rashid S . Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene. 2015; 577(2):109-18. DOI: 10.1016/j.gene.2015.11.049. View

19.

Proctor E, Mowrey D, Dokholyan N . β-Methylamino-L-alanine substitution of serine in SOD1 suggests a direct role in ALS etiology. PLoS Comput Biol. 2019; 15(7):e1007225. PMC: 6668853. DOI: 10.1371/journal.pcbi.1007225. View

20.

Hardiman O, Al-Chalabi A, Chio A, Corr E, Logroscino G, Robberecht W . Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017; 3:17071. DOI: 10.1038/nrdp.2017.71. View